» Articles » PMID: 35046097

Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia

Abstract

Significance: AML remains recalcitrant to treatments due to the emergence of resistant clones. We show a leukemia-cell nonautonomous progression mechanism that involves activation of a kynurenine-HTR1B-SAA-IDO1 axis between AML cells and osteoblasts. Targeting the niche by interrupting this axis can be pharmacologically harnessed to hamper AML progression and overcome therapy resistance. This article is highlighted in the In This Issue feature, p. 873.

Citing Articles

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment.

Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W Biomark Res. 2024; 12(1):96.

PMID: 39227970 PMC: 11373140. DOI: 10.1186/s40364-024-00646-1.


Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and T cell dysfunction.

Liu Y, Chen S, Wan X, Wang R, Luo H, Chang C Cancer Commun (Lond). 2024; 44(11):1261-1286.

PMID: 39221971 PMC: 11570772. DOI: 10.1002/cac2.12608.


Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression.

Urs A, Goda C, Kulkarni R Ann Transl Med. 2024; 12(4):63.

PMID: 39118939 PMC: 11304419. DOI: 10.21037/atm-23-1824.


Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms.

Guilatco A, Shah M, Weivoda M J Bone Oncol. 2024; 47:100620.

PMID: 39072049 PMC: 11280103. DOI: 10.1016/j.jbo.2024.100620.


Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.

Mendes M, Monteiro A, Neto E, Barrias C, Sobrinho-Simoes M, Duarte D Int J Mol Sci. 2024; 25(8).

PMID: 38674015 PMC: 11050723. DOI: 10.3390/ijms25084430.


References
1.
Schepers K, Campbell T, Passegue E . Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell Stem Cell. 2015; 16(3):254-67. PMC: 4391962. DOI: 10.1016/j.stem.2015.02.014. View

2.
Koblish H, Hansbury M, Bowman K, Yang G, Neilan C, Haley P . Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. Mol Cancer Ther. 2010; 9(2):489-98. DOI: 10.1158/1535-7163.MCT-09-0628. View

3.
Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View

4.
Dong L, Yu W, Zheng H, Loh M, Bunting S, Pauly M . Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature. 2016; 539(7628):304-308. PMC: 5317374. DOI: 10.1038/nature20131. View

5.
Visnjic D, Kalajzic Z, Rowe D, Katavic V, Lorenzo J, Aguila H . Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004; 103(9):3258-64. DOI: 10.1182/blood-2003-11-4011. View